Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Pozycja w akcjach #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Cena akcji
$2.49
Kapitalizacja rynkowa
$4.47M
Zmiana (1 dzień)
-4.01%
Zmiana (1 rok)
678.16%
Kraj
MY
Handel BioNexus Gene Lab Corporation (BGLC)

Kategoria

Wskaźnik P/B dla BioNexus Gene Lab Corporation (BGLC)
Wskaźnik P/B na dzień March 2026 TTM: 0.59
Według najnowszych raportów finansowych i ceny akcji BioNexus Gene Lab Corporation, obecny wskaźnik P/B (TTM) wynosi 0.59. Na koniec 2023 wynosił 0.95.
Historia wskaźnika P/B dla BioNexus Gene Lab Corporation od 2016 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US